Business Description
Syros Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US87184Q2066
Compare
Compare
Traded in other countries / regions
SYRS.USA0LC7.UK IPO Date
2018-01-25Description
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 4.73 | |||||
9-Day RSI | 21.63 | |||||
14-Day RSI | 33.49 | |||||
12-1 Month Momentum % | -99.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -25920.73 | |||||
OCF Margin % | -25910.88 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 25.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syros Pharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.386 | ||
| EPS (TTM) ($) | -3.07 | ||
| Beta | 1.9807 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.06 | ||
| Volatility % | 364.47 | ||
| 14-Day RSI | 33.49 | ||
| 14-Day ATR ($) | 0.000016 | ||
| 20-Day SMA ($) | 0.00011 | ||
| 12-1 Month Momentum % | -99.18 | ||
| 52-Week Range ($) | 0.0001 - 0.028 | ||
| Shares Outstanding (Mil) | 26.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syros Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syros Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 08:30 | In 132 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 131 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 | In 40 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 40 days | ||
| General meeting for 2025 | 2026-07-13 | In 8 days | ||
| First quarter earnings conference call for 2026 | 2026-07-10 | In 5 days | ||
| First quarter earnings results for 2026 | 2026-07-10 | In 5 days | ||
| First quarter earnings conference call for 2026 | 2026-05-15 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-04-06 | 0.00 (+0.00%) |
Show
Entries
Syros Pharmaceuticals Inc Frequently Asked Questions
What is Syros Pharmaceuticals Inc(LTS:0LC7)'s stock price today?
The current price of LTS:0LC7 is $0.00. The 52 week high of LTS:0LC7 is $0.03 and 52 week low is $0.00.
When is next earnings date of Syros Pharmaceuticals Inc(LTS:0LC7)?
The next earnings date of Syros Pharmaceuticals Inc(LTS:0LC7) is 2026-07-10 Est..
Does Syros Pharmaceuticals Inc(LTS:0LC7) pay dividends? If so, how much?
Syros Pharmaceuticals Inc(LTS:0LC7) does not pay dividend.
Press Release
Articles on Syros Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers